C26 H27 N5 O2
A1JVT
6,7-dimethoxy-4-[4-[5-(phenylmethyl)pyrimidin-2-yl]piperazin-1-yl]quinoline
Description
Physiochemical properties
Bound structures
Interaction statistics
Ligand-specific databases
We have redesigned this page to enhance your experience. Take an on-page tour.
Synonyms
6,7-dimethoxy-4-[4-[5-(phenylmethyl)pyrimidin-2-yl]piperazin...Show more
Formula
Standard InChI
InChI=1S/C26H27N5O2/c1-32-24-15-21-22(16-25(24)33-2)27-9-8-23(21)30-10-12-31(13-11-30)26-28-17-20(18-29-26)14-19-6-4-3-5...Show more
Standard InChI Key
YPUNTOXETHOQDC-UHFFFAOYSA-N
SMILES
COc1cc2c(ccnc2cc1OC)N3CCN(CC3)c4ncc(cn4)Cc5ccccc5
Source OpenEye
First observed in
Overall view, and highlighted
scaffolds and fragments ![help icon]()
This image gallery displays several views of the ligand structure:
- Basic Structural Representation: Shows the overall structure of the ligand.
- Detailed Structural Representation: Highlights individual atoms within the ligand.
- Murcko Scaffold: Presents the scaffold of the ligand highlighted in yellow.
- Highlighted Fragments: Displays various ligand fragments, highlighted in yellow.
This image gallery displays several views of the ligand structure:
- Basic Structural Representation: Shows the overall structure of the ligand.
- Detailed Structural Representation: Highlights individual atoms within the ligand.
- Murcko Scaffold: Presents the scaffold of the ligand highlighted in yellow.
- Highlighted Fragments: Displays various ligand fragments, highlighted in yellow.
Displayed: 1 / 2